Study to identify predictor of hypoxia in COVID-19 infection: A single-center, retrospective study.

Rai, Deependra K; Thakur, Somesh · J Family Med Prim Care · 2021

retrospective_cohort · Level III

Where this comes from

Abstract

Given the limited availability of critical care resources in our country, it is important to identify reliable predictors of hypoxia in patients with COVID-19 infection. We thus sought to compare differential predictive values of demographic, clinical, and laboratory measures and identify predictor for hypoxia in COVID-19 infection. This is single-center retrospective analysis of patient admitted at AIIMS Patna between 15<sup>th</sup> June and 15<sup>th</sup> Aug. All the patients who had oxygen saturation less than 94% grouped under hypoxic group while ≥94% in non-hypoxic group at room air. Statistical analysis: Logistic regression model used to determine the predictor of hypoxia in COVID-19 infection. Total 73 were used for analysis. Study patients had a mean age of 55.05 ± 12.7 year, of whom 78.08% were male (57/73). 39 (53.42%) patients were found hypoxic at time of admission while 34 (46.56%) were non-hypoxic. Presence of dyspnoea significantly found more frequently in hypoxic patients (<i>P</i> = 0.0003). Patients with O2 saturation of less than 94% have more likely to have diabetes (<i>P</i> = 0.002) and hypertension (<i>P</i> = 0.02). Analysis of laboratory variables showed that leucocytosis (<i>P</i> = 0.007) and neutrophilia (<i>P</i> = 0.01) were significantly higher in hypoxic group compare to non-hypoxic group. Univariate regression model showed patient with any one comorbidities, diabetes, or hypertension was found as strong risk factor for hypoxia after COVID-19 infection (<i>P</i> < 0.05). This is the first study to identify predictor of hypoxia in COVID-19 infection. Patient with any one comorbidities, diabetes, or hypertension was found strong risk factor for hypoxia after COVID-19 infection. Among lab variable, leucocytosis, neutrophilia, lymphocytopenia, and CRP (>27.5 mg/L) were found as predictor of hypoxia in COVID infection.